Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22399 | 383 | 42.4 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
90 | 3 | MATHEMATICAL & COMPUTATIONAL BIOLOGY//BIOINFORMATICS//BMC BIOINFORMATICS | 77178 |
868 | 2 | BMC BIOINFORMATICS//MATHEMATICAL & COMPUTATIONAL BIOLOGY//BIOINFORMATICS | 11572 |
22399 | 1 | LUNG CANCER DIAGNOSIS AND PROGNOSIS//AIRWAY EPITHELIUM DEVELOPMENT//ANAT CYTOL PATHOL ALBERT BONNIOT | 383 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LUNG CANCER DIAGNOSIS AND PROGNOSIS | authKW | 159452 | 1% | 100% | 2 |
2 | AIRWAY EPITHELIUM DEVELOPMENT | authKW | 79726 | 0% | 100% | 1 |
3 | ANAT CYTOL PATHOL ALBERT BONNIOT | address | 79726 | 0% | 100% | 1 |
4 | ARIZONA COMPREHENS CANC | address | 79726 | 0% | 100% | 1 |
5 | ASSOCIATION MODULE | authKW | 79726 | 0% | 100% | 1 |
6 | BEIJING CANC HOSP ETIOL ONCOL | address | 79726 | 0% | 100% | 1 |
7 | BELLEVUE CHEST SERV ENVIRONM MED | address | 79726 | 0% | 100% | 1 |
8 | BELLEVUE CHEST SERV MED | address | 79726 | 0% | 100% | 1 |
9 | BELLEVUE CHEST SERV MICROBIOL | address | 79726 | 0% | 100% | 1 |
10 | BIOMARCADO GRP RTICC RD12 0036 0040 | address | 79726 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5506 | 61% | 0% | 235 |
2 | Respiratory System | 1143 | 15% | 0% | 56 |
3 | Genetics & Heredity | 300 | 13% | 0% | 49 |
4 | Mathematical & Computational Biology | 249 | 5% | 0% | 19 |
5 | Cell Biology | 144 | 12% | 0% | 45 |
6 | Biotechnology & Applied Microbiology | 129 | 9% | 0% | 35 |
7 | Pathology | 112 | 5% | 0% | 21 |
8 | Critical Care Medicine | 51 | 3% | 0% | 10 |
9 | Biochemical Research Methods | 36 | 4% | 0% | 16 |
10 | Biochemistry & Molecular Biology | 32 | 12% | 0% | 47 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANAT CYTOL PATHOL ALBERT BONNIOT | 79726 | 0% | 100% | 1 |
2 | ARIZONA COMPREHENS CANC | 79726 | 0% | 100% | 1 |
3 | BEIJING CANC HOSP ETIOL ONCOL | 79726 | 0% | 100% | 1 |
4 | BELLEVUE CHEST SERV ENVIRONM MED | 79726 | 0% | 100% | 1 |
5 | BELLEVUE CHEST SERV MED | 79726 | 0% | 100% | 1 |
6 | BELLEVUE CHEST SERV MICROBIOL | 79726 | 0% | 100% | 1 |
7 | BIOMARCADO GRP RTICC RD12 0036 0040 | 79726 | 0% | 100% | 1 |
8 | BIOMED IBIMEDHLTH SCI PROGRAM | 79726 | 0% | 100% | 1 |
9 | BIOMOL MED TECHNOL | 79726 | 0% | 100% | 1 |
10 | CANC CLIN SAMSUNG BIOMED | 79726 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL CANCER RESEARCH | 5486 | 8% | 0% | 32 |
2 | BMC MEDICAL GENOMICS | 5338 | 2% | 1% | 7 |
3 | JOURNAL OF THORACIC ONCOLOGY | 4276 | 3% | 0% | 12 |
4 | CLINICAL LUNG CANCER | 2616 | 1% | 1% | 5 |
5 | CANCER GENOMICS & PROTEOMICS | 1515 | 1% | 1% | 2 |
6 | LUNG CANCER | 1446 | 2% | 0% | 9 |
7 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 1246 | 1% | 0% | 4 |
8 | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 777 | 1% | 0% | 5 |
9 | PLOS ONE | 621 | 10% | 0% | 38 |
10 | AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 515 | 2% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RINGNER, M , STAAF, J , (2016) CONSENSUS OF GENE EXPRESSION PHENOTYPES AND PROGNOSTIC RISK PREDICTORS IN PRIMARY LUNG ADENOCARCINOMA.ONCOTARGET. VOL. 7. ISSUE 33. P. 52957 -52973 | 32 | 63% | 0 |
2 | PETROSYAN, F , DAW, H , HADDAD, A , SPIRO, T , SOOD, R , (2015) GENE EXPRESSION PROFILING FOR EARLY-STAGE NSCLC.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. VOL. 38. ISSUE 1. P. 103 -107 | 27 | 71% | 1 |
3 | OKAYAMA, H , SCHETTER, AJ , ISHIGAME, T , ROBLES, AI , KOHNO, T , YOKOTA, J , TAKENOSHITA, S , HARRIS, CC , (2014) THE EXPRESSION OF FOUR GENES AS A PROGNOSTIC CLASSIFIER FOR STAGE I LUNG ADENOCARCINOMA IN 12 INDEPENDENT COHORTS.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 23. ISSUE 12. P. 2884 -2894 | 27 | 63% | 6 |
4 | KRATZ, JR , HE, JX , VAN DEN EEDEN, SK , ZHU, ZH , GAO, W , PHAM, PT , MULVIHILL, MS , ZIAEI, F , ZHANG, HR , SU, B , ET AL (2012) A PRACTICAL MOLECULAR ASSAY TO PREDICT SURVIVAL IN RESECTED NON-SQUAMOUS, NON-SMALL-CELL LUNG CANCER: DEVELOPMENT AND INTERNATIONAL VALIDATION STUDIES.LANCET. VOL. 379. ISSUE 9818. P. 823 -832 | 20 | 53% | 101 |
5 | SUBRAMANIAN, J , SIMON, R , (2010) GENE EXPRESSION-BASED PROGNOSTIC SIGNATURES IN LUNG CANCER: READY FOR CLINICAL USE?.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 102. ISSUE 7. P. 464-474 | 18 | 58% | 153 |
6 | CHEN, GA , KIM, S , TAYLOR, JMG , WANG, ZW , LEE, O , RAMNATH, N , REDDY, RM , LIN, J , CHANG, AC , ORRINGER, MB , ET AL (2011) DEVELOPMENT AND VALIDATION OF A QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION CLASSIFIER FOR LUNG CANCER PROGNOSIS.JOURNAL OF THORACIC ONCOLOGY. VOL. 6. ISSUE 9. P. 1481 -1487 | 23 | 53% | 7 |
7 | KRATZ, JR , THAM, PT , MULVIHILL, MS , ZIAEI, F , RAY, MR , HURST, JW , SEGAL, MR , BERRYMAN, DM , CHU, WJ , HE, B , ET AL (2013) ANALYTICAL VALIDATION OF A PRACTICAL MOLECULAR ASSAY PROGNOSTIC OF SURVIVAL IN NONSQUAMOUS NON-SMALL CELL LUNG CANCER.DIAGNOSTIC MOLECULAR PATHOLOGY. VOL. 22. ISSUE 2. P. 65 -69 | 18 | 64% | 2 |
8 | AGULLO-ORTUNO, MT , LOPEZ-RIOS, F , PAZ-ARES, L , (2010) LUNG CANCER GENOMIC SIGNATURES.JOURNAL OF THORACIC ONCOLOGY. VOL. 5. ISSUE 10. P. 1673-1691 | 45 | 26% | 17 |
9 | SRIRAM, KB , LARSEN, JE , YANG, IA , BOWMAN, RV , FONG, KM , (2011) GENOMIC MEDICINE IN NON-SMALL CELL LUNG CANCER: PAVING THE PATH TO PERSONALIZED CARE.RESPIROLOGY. VOL. 16. ISSUE 2. P. 257 -263 | 27 | 41% | 9 |
10 | NEUMANN, J , FEUERHAKE, F , KAYSER, G , WIECH, T , AUMANN, K , PASSLICK, B , FISCH, P , WERNER, M , ZUR HAUSEN, A , (2010) GENE EXPRESSION PROFILES OF LUNG ADENOCARCINOMA LINKED TO HISTOPATHOLOGICAL GRADING AND SURVIVAL BUT NOT TO EGF-R STATUS: A MICROARRAY STUDY.BMC CANCER. VOL. 10. ISSUE . P. - | 21 | 49% | 6 |
Classes with closest relation at Level 1 |